SHERIDAN, WYOMING – May 19, 2025 – Schattdecor US has announced a significant leadership transition, appointing David Sheehan as CEO and Matthias Geisler as CTO, effective October 14, 2024. The new dual leadership model reflects the company’s ongoing growth strategy in the North American surface solutions market and reinforces its commitment to innovation, customer satisfaction, and operational excellence.

Strategic Leadership Transition Anchors Future Growth

The leadership change follows the planned departure of longtime CEO Flavio Nunes, who will return to Brazil in July 2025 after nearly a decade leading Schattdecor’s U.S. operations. Under his stewardship, the company achieved several milestones, including expanded production capacity and the acquisition of a lacquering facility in Lexington, South Carolina.

SHERIDAN, WYOMING – May 19, 2025 – Hettich, one of the world’s leading manufacturers of furniture fittings, is gearing up to unveil its latest innovations under the theme “Transforming Spaces – with Innovative Motion.” at Interzum 2025 in Cologne. The event, taking place from May 20 to 23, will see Hettich deliver a strategic and immersive experience that underscores its role as a holistic solutions partner for the global furniture, fabrication, and appliance manufacturing industries.

Strategic Engagement at Interzum 2025

SHERIDAN, WYOMING – May 19, 2025 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, has announced the successful completion of a $250 million strategic investment from global investment powerhouse KKR. The transaction marks a pivotal growth move, with KKR acquiring approximately 12% of Henry Schein’s common shares and strengthening its governance role with the appointment of two prominent executives to the company’s Board of Directors.

Strategic Growth Backed by Capital and Expertise

SHERIDAN, WYOMING - May 19, 2025 - Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, will present at the Jefferies Global Healthcare Conference on June 4, 2025. The event will be held at the Marriott Marquis in New York City, with Henry Schein's session scheduled for 1:20 p.m. Eastern Time.

This high-profile investor appearance underscores Henry Schein's continued momentum in delivering comprehensive health care solutions and showcases its strategic focus on long-term shareholder value, operational innovation, and global market leadership.

Highlighting Growth Strategy at a Premier Investor Forum

SHERIDAN, WYOMING – May 19, 2025 – Royal Philips has announced the European launch of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter, marking a significant step in transforming structural heart procedures through minimally invasive, real-time imaging technology. Already established in the U.S. market, this cutting-edge device supports more efficient, patient-friendly interventions without requiring general anesthesia — a major development for healthcare providers facing rising demands in structural heart disease care.

Revolutionizing Intracardiac Imaging and Clinical Workflows

VeriSight Pro introduces a miniaturized ultrasound probe at the tip of a steerable catheter, just 3 millimeters in diameter, enabling detailed 2D and 3D imaging directly inside the heart. This innovation allows physicians to perform complex interventions with increased confidence, streamlined workflows, and reduced procedural burden.

SHERIDAN, WYOMING – May 19, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the successful pricing of a €1 billion dual-tranche bond issuance under its European Medium Term Note (EMTN) program, marking a strategic step to reinforce its capital structure and advance sustainable investment goals.

The offering consists of €500 million in fixed-rate notes due 2030 and another €500 million in notes due 2035. This financial move is designed to refinance existing 2026 debt maturities and fund eligible green projects as defined in the company’s Sustainable Finance Framework. With significant investor interest, both tranches were heavily oversubscribed—by more than three times for the 2030 notes and more than four times for the 2035 notes—underscoring strong market confidence in Philips’ long-term strategy and ESG commitments.

Strategic Financial Optimization with ESG Integration

SHERIDAN, WYOMING – May 19, 2025 – Teleste has announced the launch of the Luminato X32, a compact, high-performance Edge QAM solution that is set to transform how network operators deliver broadcast television in diverse environments. Designed for maximum efficiency and flexibility, the Luminato X32 provides a scalable, cost-effective way to distribute high-quality TV signals at the network edge—enhancing service reliability while reducing operational costs.

Future-Proofing Broadcast Delivery at the Network Edge

SHERIDAN, WYOMING – May 18, 2025 – In a move poised to reshape the regional dynamics of the furniture hardware sector, Hettich and FGV have officially launched Hettich Vietnam, their first joint subsidiary. This strategic initiative reflects both companies’ commitment to long-term growth in Southeast Asia and underscores their shared vision of delivering innovative, localized solutions to the fast-expanding Vietnamese furniture industry.

Strategic Expansion Targets Southeast Asia’s Growth Potential

The launch of Hettich Vietnam marks a significant milestone for the two family-owned companies as they consolidate their global partnership. Recognizing Vietnam's rapid urbanization and increasing demand for premium interior solutions, the new subsidiary is positioned to deliver tailored, high-quality products while embedding both companies more deeply within the regional value chain.

SHERIDAN, WYOMING – May 17, 2025 – Danaher Corporation has achieved a historic milestone in genomic medicine, enabling the development and delivery of the world’s first personalized mRNA-based CRISPR therapy for an infant with a life-threatening genetic disorder—in under six months. Powered by the Danaher Business System (DBS), this breakthrough exemplifies how disciplined innovation and cross-company collaboration can dramatically accelerate biopharmaceutical timelines and patient impact.

Compressing an 18-Month Timeline into Six

The urgency was real: an infant diagnosed with neonatal-onset CPS1 deficiency—a rare urea cycle disorder causing fatal ammonia accumulation—needed a cure in weeks, not years. DBS, Danaher’s proprietary system of operational tools and methodologies, allowed teams to strip away inefficiencies and take bold, calculated action.

SHERIDAN, WYOMING – May 17, 2025 – Danaher Corporation is reinforcing its position at the forefront of life sciences and diagnostics innovation through its Beacon program—an initiative designed to transform cutting-edge academic research into scalable, market-ready solutions. Spearheaded by Vanessa Almendro, PhD, MBA, Vice President, Head of Science and Technology Innovation at Danaher, the Beacon model exemplifies how strategic academic-industry collaboration can generate high-impact innovations aligned with real-world healthcare and biotechnology challenges.

A Structured Pathway from Discovery to Deployment